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HE finding of a positive bacteriological culture in
cerebrospinal fluid (CSF) withdrawn from a ven-
triculoperitoneal shunt is usually indicative of a
shunt infection and is typically treated as such, particu-
larly when symptoms suggestive of infection exist. Oc-
casionally, a positive bacteriological culture is obtained
from a piece of shunt tubing or valve material that is re-
moved at the time of a shunt revision, in the absence of
symptoms that would normally indicate shunt infection.
We were concerned that such a finding might be a sign of
shunt infection, and in January 1990 we initiated routine
bacteriological cultures of shunt components removed at
the time of shunt revision. A review of the literature yield-
ed only one paper that specifically addressed this prob-
lem,4 and in that report the significance of a positive bac-
teriological culture in the asymptomatic patient was not
studied. 
This study was designed to determine the significance
of “asymptomatic bacteriological shunt contamination”
(ABSC), defined as the finding of positive bacteriological
culture on a ventricular shunt component in the absence
of a positive CSF culture and/or clinical evidence of in-
fection. It was hypothesized that there were two possible
ways in which the ABSC could be significant: 1) the pres-
ence of the ABSC on the shunt might contribute to shunt
malfunction, which would lead to a revision at which the
organism is identified; and 2) the presence of ABSC might
result in a higher failure rate for the revised shunt than
would normally be expected. It was further hypothesized
that if bacterial contamination was a significant factor in
causing shunt failure, it could produce shunt blockage, but
would not be expected to cause a mechanical problem
such as a disconnected or broken shunt. If so, a positive
bacteriological culture obtained in a blocked shunt would
be significant and could result in future shunt failure,
whereas a positive culture found in a shunt malfunction-
ing for mechanical reasons or in one that was functioning
well and was being lengthened electively would represent
an inconsequential contaminant with no prognostic impli-
cations.
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U The purpose of this study was to determine the significance of “asymptomatic bacteriological shunt contamination”
(ABSC), defined as a positive bacteriological culture found on a ventricular shunt component in the absence of bacte-
ria in the cerebrospinal fluid (CSF) culture and/or clinical evidence of infection. 
Of 174 ventriculoperitoneal shunt revisions, 19 cases of ABSC were identified and reviewed retrospectively. In all
but one case, no antibiotic medications were instituted because of the positive bacteriological culture. The most com-
mon infecting organisms were coagulase-negative staphylococci (seven) and propionibacteria (eight). A comparison
of the 19 study cases with the authors’ overall shunt experience, as documented in the British Columbia’s Children’s
Hospital shunt database for the time period of the study, lead the authors to suggest that ABSC was not of significance
in causing the shunt failure at which contamination was identified and, more importantly, did not increase the risk of
future shunt malfunction.
The results of this study indicate that in the absence of clinical evidence of shunt infection or a positive bacterio-
logical culture from CSF, bacteria in a shunt component removed at revision in a child almost always represents a con-
taminant that may be ignored. Therefore, the authors advise that routine culture of shunt components removed at revi-
sion of a shunt is not indicated.




Clinical Material and Methods
The records of the Division of Pediatric Neurosurgery
and those of the Health Records Department at British
Columbia’s Children’s Hospital (BCCH) were searched
to identify all patients who underwent ventriculoperito-
neal shunt revisions between January 1, 1990, and June
30, 1993. From this group of cases were identified those
index operations associated with a positive bacteriological
culture on shunt tubing or a shunt valve that had been
removed at the time of shunt revision in the face of either
negative cultures of the CSF or no cultures of CSF. The
cut-off date of January 1, 1990, was chosen because prior
to that date, shunt components were not sent to the labo-
ratory routinely for bacteriological examination in asymp-
tomatic patients, but tended to be sent only when there
was concern about possible infection, based on intraoper-
ative findings such as excessive debris or discoloration of
the shunt component. Beginning in January 1990, shunt
components removed at the time of shunt revision were
routinely sent to the laboratory for culture analysis. 
We reviewed the records of these index cases to obtain
information concerning the age of the patient at the time
of the operation, the cause of the hydrocephalus, the rea-
son for the shunt revision, what components of the shunt
were removed at revision, the results of cultures of the
CSF and shunt components, the use of perioperative and
postoperative antibiotic medications, the date of the im-
mediately preceding shunt operation and the reason for it,
the date of the shunt revision immediately following the
index event if a shunt revision was performed and the rea-
son for it, and the time of the last follow-up assessment.
We hypothesized that if bacterial contamination was a
significant factor in causing shunt failure, one could ex-
pect the contamination to be the cause of a shunt block-
age but not of a mechanical problem such as a discon-
nected or broken shunt. If so, a positive bacteriological
culture obtained from a blocked shunt could be clinically
significant and might be associated with future shunt fail-
ure, whereas a positive culture found in a shunt malfunc-
tioning for mechanical reasons or in one that was func-
tioning well and was being lengthened electively might
represent an inconsequential contaminant with no prog-
nostic implications. The data were analyzed to test this
hypothesis. 
A database previously established for pediatric shunt
procedures in the Division of Pediatric Neurosurgery at
BCCH was made available for analysis.
Data collection and analysis were performed using
commercially available software programs (Excel, Micro-
soft Corp., Bothell, WA, and Statview, Abacus Concepts
Inc., Berkeley, CA, respectively). Shunt survival curves
were compared using a log-rank test. 
In the operating room, either the whole or part of the
shunt was placed into a capped sterile tube and transport-
ed “dry” to the laboratory, with no special measures un-
dertaken to preserve anaerobic bacteria. If removed, the
entire valve or reservoir was sent for culture, but often
only the distal end of the peritoneal catheter and the tip
of the ventricular catheter were cut off and cultured.
Cerebrospinal fluid was usually, but not always, cultured;
in this case, the sample was collected into a capped sterile
tube and sent directly to the laboratory. Sometimes, a sep-
arate sample of CSF was examined for cell count. Shunt
tracts and wounds were not cultured routinely.
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TABLE 1
Etiology of hydrocephalus in 18 patients with asymptomatic
shunt contamination
Etiology No. of Patients
meningomyelocele 7 
intraventricular hemorrhage 4 
congenital communicating 2 
aqueductal stenosis 1 
tumor 1 
encephalocele 1 
interhemispheric cyst 1 
craniosynostosis 1
FIG. 1. Graphs showing time to revision in shunts reviewed in
this study and those listed in the shunt database at British Colum-
bia’s Children’s Hospital (BCCH). Upper: The time to revision
of the 19 study shunts that at revision were found to be “contami-
nated” is compared with the overall BCCH experience of shunts
that were revised for reasons other than infection during the time
period of the study. Lower: The time to revision of the study
shunts that at revision were found to be “contaminated” with coag-
ulase-negative Staphylococcus species is compared with those con-
taminated with Propionibacterium acnes and with the overall
BCCH experience of shunts that were revised for reasons other
than infection during the time period of the study. ABSC = asymp-
tomatic bacteriological shunt contamination.
Throughout the duration of the study, the bacteriologi-
cal laboratory protocol for the handling of CSF specimens
was generally uniform. For each sample of CSF, four
culture media were used. These media included two types
of enrichment media (brain–heart infusion broth and pre-
reduced thioglycolate broth) and two solid media (blood
agar and enriched chocolate agar media). The liquid me-
dia were maintained for 7 days and the solid media were
examined for 5 days after incubation in a CO2-enhanced
atmosphere. Shunt components were generally cultured in
prereduced thioglycolate broth alone. 
Results
Between January 1, 1990, and June 30, 1993, 19 shunt
revisions were identified at which positive bacteriological
cultures were obtained from shunt components that were
removed in the absence of a positive bacteriological CSF
culture and in the absence of clinical evidence of shunt
infection (index revisions). There were 174 shunt revi-
sions performed during that time, giving the rate of ABSC
at 10.9%; the shunt infection rate was 4.1% of the total
291 shunt insertions and revisions performed during that
period.
Etiology of Hydrocephalus
The 19 shunt revisions were performed in 18 patients;
the etiology of the hydrocephalus in those patients was in
keeping with the distribution of usual causes of hydro-
cephalus at our institution (Table 1).
Bacteriological Results
Of the 19 instances of ABSC, 14 had negative CSF
cultures and five had no CSF cultures performed at the
time of shunt revision. The most common organisms
cultured from a shunt component were coagulase-nega-
tive Staphylococcus species and Propionibacterium acnes
(Table 2). In one patient there were two episodes of
ABSC; in this case the organism cultured from the shunt
component at the time of the second revision was differ-
ent from the organism cultured at the first shunt revision.
In four operations CSF cell counts were made, and in one
of these there was an elevation in the total number of
white blood cells with an associated increased eosinophil
count. In this child, whose shunt was contaminated with
Corynebacterium species, the shunt had to be revised else-
where 4 weeks later when the ventricular catheter migrat-
ed into the subgaleal space. 
Duration of Shunt Function Prior to Index Revision
The duration of shunt function, prior to the index revi-
sion at which bacteriological contamination was identi-
fied, was examined and compared with data from the
BCCH shunt database for the same time period. The time
to revision of the 19 shunts that were found at revision to
be contaminated was no shorter than that of shunts listed
in the BCCH database that were revised for reasons other
than infection (Fig. 1 upper). When the analysis was re-
peated, subdividing the shunts according to contamination
with coagulase-negative Staphylococcus species versus P.
acnes, the duration of prior function of these shunts in
each of these two groups was no shorter than that of the
shunts in the overall database (Fig. 1 lower). There was no
statistical difference using the log-rank test between the
survival curves for the two different organisms.
Time to Failure of Shunt Following Index Revision
The time to failure following revision of the shunt at
which ABSC was identified was compared with the fail-
ure rate of ventriculoperitoneal shunts at our institution
using the BCCH shunt database for the same time period,
and there was no difference (Fig. 2 upper). 
Correlation of Bacteriological Findings and Need for
Further Shunt Revision
For shunt revisions that were associated with posi-
tive growth of coagulase-negative Staphylococcus spe-
cies, four of seven had a repeat shunt operation at a mean
time of 6.5 months after the index shunt revision (Table
2). When the infecting organism was P. acnes, two of
eight cases underwent a later shunt revision at a mean time
of 9.5 months. In the one case in which there was a com-
bination of S. aureus and Micrococcus species, a repeat
shunt operation was necessary within 1 month. Shunt sur-
vival curves for coagulase-negative Staphylococcus
species and P. acnes are compared with the overall shunt
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TABLE 2
Relationship of organism cultured from shunt component in 19 cases of asymptomatic shunt contamination to
incidence and timing of further shunt revisions*
Time to No Duration of 
Repeat Next Shunt Repeat Follow Up if No
No. of Shunt Revision (mos) Shunt Further Revision (mos)
Organism Patients Revisions Average (range) Revision Average (range)
coagulase-negative Staphylococcus species 7 4 6.5 (0.2–18.2) 3 18.2 (9.6–25.1)
Propionibacterium acnes 8 2 9.5 (0.4–18.6) 6 26.6 (15.6–49.2)
Corynebacterium species 1 1 0.9 0 —
Corynebacterium species & Moraxella species 1 0 — 1 45.2
Staphylococcus aureus & Micrococcus species 1 1 0.8 0 —
Peptostreptococcus species 1 0 — 1 26.2
* — = not applicable.
survival curve for the BCCH shunt database in Fig. 2 cen-
ter. There was no statistical difference between the three
curves.
Relationship Between Reason for Shunt Revision and Need
for a Repeat Shunt Revision in the Future
The reasons for the index shunt revisions were tabu-
lated under three separate categories, namely: elective
lengthening; some type of shunt blockage; or mechanical
dysfunction of the shunt, such as disconnection, fracture
of the shunt tubing, or inappropriate pressure of the valve.
The data were analyzed to determine whether there was
any correlation between the reason for the shunt revision
and the need for further shunt revision; this is tabulated in
Table 3. Six of the seven cases in which shunt revision
was performed because of a shunt blockage required a fur-
ther shunt revision. There were four patients who had
elective lengthening operations, two with coagulase-nega-
tive Staphylococcus species and two with P. acnes, and
none required a further shunt revision. Of the eight pa-
tients who had mechanical problems with their shunt, one
of two patients, in whom coagulase-negative Staphylo-
coccus species was isolated from the shunt component,
required another operation on the shunt, as did one of five
with P. acnes. Using survival curves, the rate of shunt fail-
ure after revision for shunt blockage was compared with
that for shunts revised for mechanical dysfunction and
elective lengthening combined (Fig. 2 lower). There was
a significant difference between the two groups (p =
.0004, log-rank test).
Reasons for Shunt Revision After the Index Case of Shunt
Revision
Four patients in whom the shunt component was infect-
ed with coagulase-negative Staphylococcus species had a
further revision. One of these went on to have a repeat
revision for infection with S. aureus. Two patients had
revisions for a blocked shunt and one for chronic inter-
mittent headaches in the face of multiple negative CSF
cultures; in these three cases the bacteriological cultures
from the shunt components removed at the time of the
revisions were negative. The patient with S. aureus and
Micrococcus species contamination of the shunt compo-
nent returned with a frank shunt infection with S. aureus.
Two patients with P. acnes had a shunt revision; one for an
abdominal pseudocyst with a further positive culture of
P. acnes from the peritoneal catheter, and the other for
a blocked shunt, at which time the removed ventricular
catheter proved negative on bacteriological culture.
Treatment of Patients With Asymptomatic Shunt
Contamination
In only one case in this study was treatment specifical-
ly directed at eradicating the bacterial organism that might
exist in the shunt that had been left in situ. In this case of
coagulase-negative Staphylococcus species, vancomycin
was administered intravenously for 1 week in addition to
perioperative cephalothin, which had been used prophy-
lactically. This patient went on to have the shunt revised at
the end of this course of antibiotic medications for block-
age of the ventricular catheter. At that procedure the entire
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FIG. 2. Graphs depicting time to failure in shunts reviewed in
this study and those listed in the shunt database at British Colum-
bia’s Children’s Hospital (BCCH). Upper: The time to failure
of the 19 shunts revised at the time asymptomatic bacteriological
shunt contamination (ABSC) was identified is compared with the
overall BCCH shunt experience for the time period of the study.
Center: The time to failure of the shunts revised at the time ABSC
was identified is plotted for shunts contaminated with coagulase-
negative Staphylococcus species and Propionibacterium acnes,
and comparison is made with the overall BCCH shunt experience
for the time period of the study. Lower: The time to failure of the
shunts revised at the time ABSC was identified is plotted for shunts
revised for blockage (blocked) and for shunts revised for mechan-
ical dysfunction and elective lengthening combined (mechanical
failure).
shunt was replaced and cultures from the removed shunt
were negative. One patient was given no antibiotic med-
ications; all others received prophylactic cephalothin in
the perioperative period as the only antibiotic therapy. In
these 17 cases a single dose of cephalothin was given after
induction of anesthesia and before the incision was made.
This was followed by a single postoperative dose in
15 patients, and no postoperative antibiotic medications
in two. 
In two patients the entire shunt system was removed
and replaced at the time of the index ventriculoperitoneal
shunt. In both patients an additional shunt revision had to
be performed in the future. 
Discussion
Most ventricular peritoneal shunt infections are charac-
terized by a positive bacteriological culture from the CSF
removed from the shunt. Some patients have relatively
occult shunt infections, presenting as abdominal pain or
an abdominal pseudocyst in the face of persistently nega-
tive CSF cultures from the shunt reservoir; the infection
in these cases is identified only by positive cultures from
a shunt component.8,13 In these patients treatment is gen-
erally directed at eradicating the infection. The cases
described in this report, like the occult shunt infections
described above, were characterized by a positive bacteri-
ological culture from a shunt component in the absence of
a positive culture from CSF. Unlike the occult infections,
however, there were no clinical features suggestive of
infection. In this situation, which we have termed “asymp-
tomatic bacteriological shunt contamination” (ABSC), the
questions that arise are: 1) whether the positive culture,
which is typically that of a nonvirulent skin organism,
such as coagulase-negative Staphylococcus species or P.
acnes, simply represents a contaminant; 2) if not a con-
taminant, whether the shunt colonization had a role in
causing the shunt to malfunction; 3) whether the positive
culture has any prognostic implications for the future
function of the revised shunt; and 4) whether any treat-
ment is indicated.
In the only report that specifically addressed this prob-
lem, Fokes4 reported six patients who underwent ven-
triculoatrial shunt revisions because of shunt malfunction
or for elective lengthening, in whom either coagulase-neg-
ative Staphylococcus species or diphtheroids were cul-
tured from the shunt catheter. These patients had nega-
tive CSF cultures and there was no clinical suspicion of
a shunt infection. No specific treatment was instituted at
that time. Because the longest follow-up period in that
group of patients was 7 months, the long-term outcome
and, hence, the possible significance of the contamination
with respect to shunt failure are not known. In a series of
14 patients with diphtheroid shunt infections described by
Rekate, et al.,7 25% had positive bacterial cultures found
only in shunt tubing. Three of the 14 patients were said to
be “asymptomatic”: two with a ventricular drain and one
with a ventricular peritoneal shunt. However, it is not clear
whether these asymptomatic patients had positive cultures
from the shunt tubing, from CSF, or from both. All
patients were treated with revision of the shunt and antibi-
otic therapy; the long-term outcome was not reported. 
In our study, the significance of ABSC was examined
specifically. In 18 of the 19 cases of ABSC we reviewed,
the bacteria were nonvirulent skin commensal organisms,
including coagulase-negative Staphylococcus species, P.
acnes, and Corynebacterium species; and it may be ar-
gued that these positive cultures represented a contami-
nant without any significance. However, shunt infections
typically are caused by normal skin commensal organ-
isms, with coagulase-negative Staphylococcus species
being the most commonly involved,5,10 P. acnes less so
(although well documented),2,3,9,12 and Corynebacterium
rarely implicated.1,11 There are two possible ways in which
the ABSC could be significant: 1) if the presence of the
bacterial organism on the shunt contributed to shunt mal-
function and led to revision at which the organism was
identified; and 2) if the presence of ABSC resulted in a
higher failure rate for the revised shunt than would nor-
mally be expected.
Malfunction of Prior Shunt 
To address whether or not ABSC might have been a
cause of shunt malfunction leading to shunt revision, the
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TABLE 3
Relationship between the reason for shunt revision in 19 cases of asymptomatic shunt contamination and the
incidence of further shunt revisions for each infecting organism*
Reason for Shunt Revision
Shunt Blockage Elective Lengthening Mechanical Dysfunction
No. of Further No. of Further No. of Further 
Organism Patients Revision Patients Revision Patients Revision
coagulase-negative Staphylococcus species 3 3 2 0 2 1
Propionibacterium acnes 1 1 2 0 5 1
Corynebacterium species 1 1 0 — 0 —
Corynebacterium species & Moraxella species 1 0 0 — 0 —
Staphylococcus aureus & Micrococcus species 1 1 0 — 0 —
Peptostreptococcus species 0 — 0 — 1 0
total 7 6 4 0 8 2
* — = not applicable.
longevity of the shunt immediately preceding the index
revision was compared with our overall experience of
shunts that were revised for reasons other than infection,
as documented in the BCCH shunt database for the time
period of the study. The time to revision of the 19 shunts
was no shorter than that of BCCH database shunts in gen-
eral. This suggests that the bacterial contamination of the
shunt did not cause the shunt to malfunction prematurely,
resulting in the revision at which the bacterial contamina-
tion was identified. In the shunts contaminated with P.
acnes, the longevity of the shunt prior to identification of
ABSC was greater than that of shunts contaminated with
coagulase-negative Staphylococcus species or the general
population of shunts in our overall database. It is known
that P. acnes may cause shunt malfunction and infection
after a longer interval than might be the case for coagu-
lase-negative Staphylococcus species2,7,9 and it may be
that positive cultures of P. acnes in ABSC also require that
the shunt has been in situ for a long time.
Prognostic Implications for Future Shunt Function
To address whether a finding of ABSC might predis-
pose the patient to future shunt malfunction, the time to
failure of the 19 shunts revised at the time ABSC was dis-
covered was compared with our overall experience with
shunts during the time period of the study. The time to
failure of the 19 “contaminated” shunts was similar to that
of our overall population of shunts, suggesting that in gen-
eral the finding of ABSC has no prognostic implications
for future shunt malfunction. It is still possible that the
occurrence of ABSC may have a negative influence on
future shunt function but that effect may be obscured by
the high background failure rate of shunts for other rea-
sons. Therefore, the data were examined further to deter-
mine if there were any factors associated with the ABSC
that correlated with an increased risk of future shunt
failure.
Influence of Bacterial Organism
The likelihood of shunt failure during the follow-up
period was analyzed relative to the organism that was cul-
tured from the removed shunt components. Except for the
single case in which the organism was virulent, namely
S. aureus, there was no evidence that ABSC with a non-
virulent organism increased the risk of future shunt mal-
function.
Influence of Reason for Index Shunt Revision
In this study, there was a significantly increased shunt
failure rate after revision for shunt blockage compared to
that after revision for elective lengthening and mechani-
cal dysfunction. The patients with blocked shunts were
younger than those whose shunts were revised for me-
chanical reasons or elective lengthening and were gener-
ally children less than 1 year of age, with the previous
shunt operation done less than 6 months prior to the iden-
tification of shunt contamination. Even without the pres-
ence of a positive culture from a shunt component, this
group of patients would be expected to have the highest
risk of requiring a future shunt revision.6 Thus, the in-
creased failure rate after revision of blocked shunts com-
pared to that after revision for mechanical dysfunction or
elective lengthening may simply reflect the younger age
of the patient and the shorter duration of the prior shunt
procedure, and it is not clear whether the presence of the
positive culture in these patients increased the risk of
shunt failure. 
Reason for Future Shunt Revision
The reason for failure of shunts revised at the time of
identification of ABSC was examined, because it was
thought that if the shunts failed as a result of infection with
the same organism, this would indicate that the “contami-
nation” was of importance. Of the eight revised shunts
that failed, two failed because of infection with the same
organism: one the case with S. aureus and the other with
P. acnes. In the other six shunt failures bacterial shunt con-
tamination could not be directly implicated.
Conclusions
The results of this study of ABSC failed to show that
shunt colonization had a role in causing the shunt to mal-
function or that the positive culture had any negative prog-
nostic implications for the future function of the revised
shunt. The findings lead us to suggest that a positive bac-
teriological culture from a shunt component removed at
revision in a child, in the absence of clinical evidence of
shunt infection or a positive bacteriological culture from
CSF, almost always represents a contaminant; however,
no treatment is required. Therefore, we advise the reader
that routine culture of shunt components removed at revi-
sion of a shunt is not indicated and constitutes an unnec-
essary expense. 
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